Journal article
The treatment of primary intraocular malignancy
International journal of radiation oncology, biology, physics, v 15(6), pp 1355-1361
1988
PMID: 3058658
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
This paper will summarize much of the information derived in an association between The Department of Radiation Oncology of Hahnemann University Hospital and the Oncology Service of Wills Eye Hospital of Thomas Jefferson University, a collaborative effort for the treatment of primary intraocular malignancies that has spanned the last dozen years. In that time we have treated malignant intraocular melanoma by radioactive eyeplaque brachytherapy and have begun to develop a similar program for treatment of recurring retinoblastoma. These experiences will be described.
Metrics
Details
- Title
- The treatment of primary intraocular malignancy
- Creators
- Luther W. Brady - American Cancer SocietyArnold M. Markoe - Hahnemann University HospitalBeatriz E. Amendola - The Department of Radiation Oncology and Nuclear Medicine, Hahnemann University, Philadelphia, PA 19102, USAUlf L. Karlsson - Hahnemann University HospitalBizhan Micaily - Hahnemann University HospitalJerry A. Shields - Wills Eye HospitalJames J. Augsburger - Wills Eye Hospital
- Publication Details
- International journal of radiation oncology, biology, physics, v 15(6), pp 1355-1361
- Publisher
- Elsevier
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Web of Science ID
- WOS:A1988R427800013
- Scopus ID
- 2-s2.0-0024203250
- Other Identifier
- 991019183952004721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Oncology
- Radiology, Nuclear Medicine & Medical Imaging